ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
57.39
0.20
(0.35%)
Closed February 02 4:00PM
56.5985
-0.7915
(-1.38%)
After Hours: 7:59PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
56.5985
Bid
56.56
Ask
56.60
Volume
17,566,393
56.33 Day's Range 62.15
22.89 52 Week Range 79.4899
Market Cap
Previous Close
57.19
Open
60.00
Last Trade Time
Financial Volume
$ 1,040,717,809
VWAP
59.2448
Average Volume (3m)
4,901,662
Shares Outstanding
157,445,683
Dividend Yield
-
PE Ratio
-34.02
Earnings Per Share (EPS)
-1.69
Revenue
531.82M
Net Profit
-265.96M

About Tempus AI Inc

Tempus AI endeavors to unlock the true power of precision medicine by creating Intelligent Diagnostics through the practical application of artificial intelligence in healthcare. Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. ... Tempus AI endeavors to unlock the true power of precision medicine by creating Intelligent Diagnostics through the practical application of artificial intelligence in healthcare. Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. To accomplish this, we built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Our proprietary technology has allowed us to amass what we consider to be one of the largest libraries of clinical and molecular oncology data in the world. We have launched a suite of different products derived from our Platform, which have gained significant traction over the past five years. To date, our offerings have been used by approximately 95% of the largest public pharmaceutical companies. Show more

Sector
Computer Programming Service
Industry
Computer Programming Service
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Tempus AI Inc is listed in the Computer Programming Service sector of the NASDAQ with ticker TEM. The last closing price for Tempus AI was $57.19. Over the last year, Tempus AI shares have traded in a share price range of $ 22.89 to $ 79.4899.

Tempus AI currently has 157,445,683 shares outstanding. The market capitalization of Tempus AI is $9 billion. Tempus AI has a price to earnings ratio (PE ratio) of -34.02.

Tempus AI (TEM) Options Flow Summary

Overall Flow

Bullish

Net Premium

10M

Calls / Puts

1,066.67%

Buys / Sells

82.42%

OTM / ITM

69.90%

Sweeps Ratio

0.57%

TEM Latest News

Tempus Announces National Launch of olivia, its AI-enabled Personal Health Concierge App for Patients

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the national launch of olivia. olivia is an...

Tempus Announces the National Launch of FDA-Approved xT CDx Test

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the national launch of the company’s FDA-approved...

Tempus One Introduces New GenAI Capabilities to Query Millions of Unstructured Documents for Research and Clinical Care

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today introduced a suite of new, transformative capabilities...

Tempus Announces Its First-Ever, Whole-Genome Sequencing Assay, xH

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the company is developing its first whole-genome...

Tempus Announces Preliminary Fourth Quarter and Full Year 2024 Results

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced select, preliminary, unaudited results for the...

Tempus Announces a Collaboration With Genialis to Develop RNA-Based Biomarker Algorithms

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration with Genialis, the RNA-biomarker...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.59852.906363636365558.5148.08011229925552.9483069CS
422.248564.77001455634.3558.5131.36921581347.17148071CS
12-0.1915-0.33720725479856.7979.489931.36490166246.06418062CS
2610.018521.508158007746.5879.489931.36271499047.25890453CS
5216.598541.496254079.489922.89245978245.76329938CS
15616.598541.496254079.489922.89245978245.76329938CS
26016.598541.496254079.489922.89245978245.76329938CS

TEM - Frequently Asked Questions (FAQ)

What is the current Tempus AI share price?
The current share price of Tempus AI is $ 56.5985
How many Tempus AI shares are in issue?
Tempus AI has 157,445,683 shares in issue
What is the market cap of Tempus AI?
The market capitalisation of Tempus AI is USD 9B
What is the 1 year trading range for Tempus AI share price?
Tempus AI has traded in the range of $ 22.89 to $ 79.4899 during the past year
What is the PE ratio of Tempus AI?
The price to earnings ratio of Tempus AI is -34.02
What is the cash to sales ratio of Tempus AI?
The cash to sales ratio of Tempus AI is 17.01
What is the reporting currency for Tempus AI?
Tempus AI reports financial results in USD
What is the latest annual turnover for Tempus AI?
The latest annual turnover of Tempus AI is USD 531.82M
What is the latest annual profit for Tempus AI?
The latest annual profit of Tempus AI is USD -265.96M
What is the registered address of Tempus AI?
The registered address for Tempus AI is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Tempus AI website address?
The website address for Tempus AI is www.tempus.com
Which industry sector does Tempus AI operate in?
Tempus AI operates in the COMPUTER PROGRAMMING SERVICE sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCTMTCTM Kids IT Education Inc
$ 0.764
(321.87%)
729.72M
REBNReborn Coffee Inc
$ 3.31
(63.05%)
55.54M
FCUVFocus Universal Inc
$ 5.87
(56.62%)
1.73M
SOPASociety Pass Inc
$ 1.54
(56.50%)
13.82M
CYCNCyclerion Therapeutics Inc
$ 3.92
(54.33%)
82.39M
ENVBEnveric Biosciences Inc
$ 2.0899
(-46.41%)
1.58M
NIVFNewGenIvf Group Ltd
$ 0.1489
(-42.51%)
14.91M
GLSTGlobal Star Acquisition Inc
$ 8.83
(-39.10%)
23.93k
PRPHProPhase Labs Inc
$ 0.2633
(-38.02%)
900.48k
SPGCSacks Parente Golf Inc
$ 0.5601
(-37.86%)
7.42M
TCTMTCTM Kids IT Education Inc
$ 0.764
(321.87%)
731.1M
NVDANVIDIA Corporation
$ 120.07
(-3.67%)
388.5M
RIMEAlgorhythm Holdings Inc
$ 0.02565
(5.12%)
341.8M
CLEUChina Liberal Education Holdings Ltd
$ 0.1938
(30.77%)
237.15M
BHATBlue Hat Interactive Entertainment Technology
$ 0.0355
(-11.25%)
236.44M

Discussion

View Full Feed
TheDane TheDane 2 minutes ago
Tariffs already priced in? It’s not like a big surprise.
TSLA
price_and_volume price_and_volume 3 minutes ago
No I did not.
So I believe you lost money too ? I was attracted to the board for other reasons.

I stayed to debate those who believed in JK & pumped his stock(s), because it became clear to me long ago JK was a lying sack of shit.

I try to present the opposite vi
GSTC
Monksdream Monksdream 3 minutes ago
PLTR 10Q due Monday after the close
YOY growth nearly 50%
PLTR
weedtrader420 weedtrader420 3 minutes ago
President,Jerome Powell needs to be fired This week, then there should be a special meeting and the rates should be lowered a half percent.Trump needs to give every American $2000 to buy BITCOIN XRP
BTCUSD
dennisdave dennisdave 4 minutes ago
in the last 10Q NWBO stated they have contracted a third party to conduct joint trials with and engaged for a number of months in joint development of trial designs and selection of candidate cancers for a combination treatment clinical trial. Claiming thats a lie is absolutely BS

But
NWBO
firebag1 firebag1 5 minutes ago
Agreed. Significant shorting for years
HMBL
SunshineSmiles SunshineSmiles 7 minutes ago
New management with old management shares. Once those old shares are gone it will be wonderful.

MONI
MONI
blue finch blue finch 8 minutes ago
do you think we will start to see important news in february 
our earnings month 

sort of set up the investors for the good news on the 26th

best of luck 
IONQ
Louie_Louie Louie_Louie 8 minutes ago
It's halarious all the liberal socialist communists posting on the FNMA board. Bashing Trump yet they invest in what he unltimately controls and they are here hoping to get rich! LMAO ultimate hypocrites. Trump is good enough to invest with to these clowns, otherwise they go out and scream at a
Gmenfan Gmenfan 9 minutes ago
DAVID MARCUS: Liberal media's lies to protect Biden were even worse than you think

Political activists masquerading as journalists have learned little, but Americans know the score

David Marcus

Published February 2, 2025 8:55am EST


Gmenfan Gmenfan 9 minutes ago
DAVID MARCUS: Liberal media's lies to protect Biden were even worse than you think

Political activists masquerading as journalists have learned little, but Americans know the score

David Marcus

Published February 2, 2025 8:55am EST


newmedman newmedman 9 minutes ago
Take these Canadian jobs back from Canada

Take what jobs? Do you understand anything about infrastructure and supply chains? I suppose we're going to take all the jobs from Mexico too eh'. Tell us how that's going to happen sport.
georgie18 georgie18 10 minutes ago
Not yet...🥳...imo...we shall see...
BNRG
Viking61 Viking61 11 minutes ago
Biden started an increase in Government hiring during the election year and was also fudging the employment report to make his administration look better and then a month or two later after each quarter the real numbers would seep out which basically showed that much if any increase in real jobs cam
FNMA
MartinLutherKing MartinLutherKing 11 minutes ago
The time has come Feb 4 the main event
RNAZ
joe botts joe botts 11 minutes ago
Zero... that will it forever....When? You cannot be serious? Its REVOKED
Zorax Zorax 12 minutes ago
True. But the tariffs on holy water would cause the price to go through the steeple and a run on Perrier.
MartinLutherKing MartinLutherKing 12 minutes ago
The world awaits Nobel Prize Highlights MicroRNA’s Promise in Cancer Therapy

The Nobel Prize in Medicine has been awarded to Victor Ambros and Gary Ruvkun who discovered microRNA and its role in the regulation of genes.

The two scientists discovered a new principle o
BCG
rizona rizona 12 minutes ago
Here is the R&R quotes that resulted in the long-term spoofing argument being rejected:

"Accordingly, the peer-reviewed research that Plaintiff cites, showing that the price impact from the placement of an order exceeds the impact of an order cancellation, is beside the point here. Se
NWBO
al44 al44 12 minutes ago
Pete Hegseth punishes Mark Milley for arrogantly defying the president

By Susan Quinn


Given the extent of Hegseth’s actions, he’s also clearly trying to send a message to Milley: that he won’t be intimidated by anyone at the Pentagon; the president has the last
intel201 intel201 13 minutes ago
I believe history shows he does